Physician profile
Kaebah Orme-Evans
NPI 1689085433
$636.84
in general payments reported to CMS, 2019-2025
15 companies · $176 in 2025
The $176 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $74.62 · 2021: $18.49 · 2022: $64.30 · 2023: $55.70 · 2024: $248 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $479.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $176.05 | 2020-2025 | Thinprep 2000 Processor, Aptima, Acessa Provu System |
| Novo Nordisk INC | $73.56 | 2024-2025 | Wegovy |
| Organon LLC | $58.93 | 2024-2025 | Nexplanon |
| Coopersurgical, INC. | $46.35 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Astellas Pharma US INC | $44.85 | 2025 | Veozah |
| Sage Therapeutics, LLC | $39.25 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.89 | 2024-2025 | |
| Lilly USA, LLC | $30.70 | 2024 | Zepbound |
| Pfizer INC. | $29.00 | 2023-2024 | |
| Minerva Surgical, INC | $20.68 | 2025 | |
| Abbvie INC. | $20.08 | 2024 | |
| Exeltis, USA INC. | $18.49 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.70 | 2024 | Trintellix |
| Amgen INC. | $14.80 | 2024 | Prolia, Evenity |
| Exact Sciences Corporation | $13.51 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaebah Orme-Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.